| Autor: |
Corazza, Monica, Roveggio, Carla, Virgili, Annarosa |
| Předmět: |
|
| Zdroj: |
Contact Dermatitis (01051873); Oct93, Vol. 29 Issue 4, p219-219, 2/3p |
| Abstrakt: |
The article focuses on allergic contact dermatitis from bufexamac cream. Bufexamac is an arylalcanoic acid derivative. Bufexamac cream has the anti-inflammatory effect of fluocinolone acetonide cream. About 20% of patients with dermatitis had contact allergy to topical medicaments. The use of topical anti-inflammatory drugs has recently increased. There are several reports of allergy to bufexamac, though its incidence of contact sensitivity was estimated as only 0.3%. Application to broken skin increases the risk of sensitization to topical Bufexamac. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text